Literature DB >> 26091719

Differential Interaction of the Staphylococcal Toxins Panton-Valentine Leukocidin and γ-Hemolysin CB with Human C5a Receptors.

András N Spaan1, Ariën Schiepers2, Carla J C de Haas2, Davy D J J van Hooijdonk2, Cédric Badiou3, Hugues Contamin4, François Vandenesch5, Gérard Lina5, Norma P Gerard6, Craig Gerard7, Kok P M van Kessel2, Thomas Henry3, Jos A G van Strijp8.   

Abstract

Staphylococcus aureus is well adapted to the human host. Evasion of the host phagocyte response is critical for successful infection. The staphylococcal bicomponent pore-forming toxins Panton-Valentine leukocidin LukSF-PV (PVL) and γ-hemolysin CB (HlgCB) target human phagocytes through interaction with the complement receptors C5aR1 and C5aR2. Currently, the apparent redundancy of both toxins cannot be adequately addressed in experimental models of infection because mice are resistant to PVL and HlgCB. The molecular basis for species specificity of the two toxins in animal models is not completely understood. We show that PVL and HlgCB feature distinct activity toward neutrophils of different mammalian species, where activity of PVL is found to be restricted to fewer species than that of HlgCB. Overexpression of various mammalian C5a receptors in HEK cells confirms that cytotoxicity toward neutrophils is driven by species-specific interactions of the toxins with C5aR1. By taking advantage of the species-specific engagement of the toxins with their receptors, we demonstrate that PVL and HlgCB differentially interact with human C5aR1 and C5aR2. In addition, binding studies illustrate that different parts of the receptor are involved in the initial binding of the toxin and the subsequent formation of lytic pores. These findings allow a better understanding of the molecular mechanism of pore formation. Finally, we show that the toxicity of PVL, but not of HlgCB, is neutralized by various C5aR1 antagonists. This study offers directions for the development of improved preclinical models for infection, as well as for the design of drugs antagonizing leukocidin toxicity.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26091719      PMCID: PMC4506853          DOI: 10.4049/jimmunol.1500604

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

1.  Fractionation of a leucocidin from Staphylococcus aureus.

Authors:  A M WOODIN
Journal:  Biochem J       Date:  1959-10       Impact factor: 3.857

2.  Evidence for a functional role of the second C5a receptor C5L2.

Authors:  Hongwei Gao; Thomas A Neff; Ren-Feng Guo; Cecilia L Speyer; J Vidya Sarma; Scott Tomlins; Yunfang Man; Niels C Riedemann; L Marco Hoesel; Ellen Younkin; Firas S Zetoune; Peter A Ward
Journal:  FASEB J       Date:  2005-03-22       Impact factor: 5.191

3.  Characterization of a novel structural member, LukE-LukD, of the bi-component staphylococcal leucotoxins family.

Authors:  A Gravet; D A Colin; D Keller; R Girardot; H Monteil; G Prévost; R Giradot
Journal:  FEBS Lett       Date:  1998-10-02       Impact factor: 4.124

4.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.

Authors:  T Dragic; V Litwin; G P Allaway; S R Martin; Y Huang; K A Nagashima; C Cayanan; P J Maddon; R A Koup; J P Moore; W A Paxton
Journal:  Nature       Date:  1996-06-20       Impact factor: 49.962

Review 5.  Staphylococcus aureus infections.

Authors:  F D Lowy
Journal:  N Engl J Med       Date:  1998-08-20       Impact factor: 91.245

6.  The staphylococcal toxin Panton-Valentine Leukocidin targets human C5a receptors.

Authors:  András N Spaan; Thomas Henry; Willemien J M van Rooijen; Magali Perret; Cédric Badiou; Piet C Aerts; Johan Kemmink; Carla J C de Haas; Kok P M van Kessel; François Vandenesch; Gérard Lina; Jos A G van Strijp
Journal:  Cell Host Microbe       Date:  2013-05-15       Impact factor: 21.023

7.  Interaction of the two components of leukocidin from Staphylococcus aureus with human polymorphonuclear leukocyte membranes: sequential binding and subsequent activation.

Authors:  D A Colin; I Mazurier; S Sire; V Finck-Barbançon
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities.

Authors:  G Prévost; B Cribier; P Couppié; P Petiau; G Supersac; V Finck-Barbançon; H Monteil; Y Piemont
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

Review 9.  The effects of Staphylococcus aureus leukotoxins on the host: cell lysis and beyond.

Authors:  Pauline Yoong; Victor J Torres
Journal:  Curr Opin Microbiol       Date:  2013-02       Impact factor: 7.934

10.  Complete nucleotide sequence and molecular characterization of the temperate staphylococcal bacteriophage phiPVL carrying Panton-Valentine leukocidin genes.

Authors:  J Kaneko; T Kimura; S Narita; T Tomita; Y Kamio
Journal:  Gene       Date:  1998-07-17       Impact factor: 3.688

View more
  37 in total

1.  Human CD45 is an F-component-specific receptor for the staphylococcal toxin Panton-Valentine leukocidin.

Authors:  Angelino T Tromp; Michiel Van Gent; Pauline Abrial; Amandine Martin; Joris P Jansen; Carla J C De Haas; Kok P M Van Kessel; Bart W Bardoel; Elisabeth Kruse; Emilie Bourdonnay; Michael Boettcher; Michael T McManus; Christopher J Day; Michael P Jennings; Gérard Lina; François Vandenesch; Jos A G Van Strijp; Robert Jan Lebbink; Pieter-Jan A Haas; Thomas Henry; András N Spaan
Journal:  Nat Microbiol       Date:  2018-05-07       Impact factor: 17.745

2.  Reducing the Bottleneck in Discovery of Novel Antibiotics.

Authors:  Marcus B Jones; William C Nierman; Yue Shan; Bryan C Frank; Amy Spoering; Losee Ling; Aaron Peoples; Ashley Zullo; Kim Lewis; Karen E Nelson
Journal:  Microb Ecol       Date:  2016-11-28       Impact factor: 4.552

Review 3.  Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity.

Authors:  E Sachiko Seilie; Juliane Bubeck Wardenburg
Journal:  Semin Cell Dev Biol       Date:  2017-04-23       Impact factor: 7.727

Review 4.  Leukocidins: staphylococcal bi-component pore-forming toxins find their receptors.

Authors:  András N Spaan; Jos A G van Strijp; Victor J Torres
Journal:  Nat Rev Microbiol       Date:  2017-04-19       Impact factor: 60.633

5.  Critical Role of Alpha-Toxin and Protective Effects of Its Neutralization by a Human Antibody in Acute Bacterial Skin and Skin Structure Infections.

Authors:  Vien T M Le; Christine Tkaczyk; Sally Chau; Renee L Rao; Etyene Castro Dip; Eliane P Pereira-Franchi; Lily Cheng; Sally Lee; Holly Koelkebeck; Jamese J Hilliard; Xiang Qing Yu; Vivekananda Datta; Vien Nguyen; William Weiss; Laszlo Prokai; Terrence O'Day; C Kendall Stover; Bret R Sellman; Binh An Diep
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

Review 6.  Targeting fundamental pathways to disrupt Staphylococcus aureus survival: clinical implications of recent discoveries.

Authors:  Isaac P Thomsen; George Y Liu
Journal:  JCI Insight       Date:  2018-03-08

7.  Safety and immunogenicity of a recombinant Staphylococcus aureus α-toxoid and a recombinant Panton-Valentine leukocidin subunit, in healthy adults.

Authors:  Michael L Landrum; Tahaniyat Lalani; Minoo Niknian; Jason D Maguire; Duane R Hospenthal; Ali Fattom; Kimberly Taylor; Jamie Fraser; Kenneth Wilkins; Michael W Ellis; Paul D Kessler; Rafaat E F Fahim; David R Tribble
Journal:  Hum Vaccin Immunother       Date:  2016-12-23       Impact factor: 3.452

8.  Production of Staphylococcal Complement Inhibitor (SCIN) and Other Immune Modulators during the Early Stages of Staphylococcus aureus Biofilm Formation in a Mammalian Cell Culture Medium.

Authors:  Andi R Sultan; Jasper W Swierstra; Nicole A Lemmens-den Toom; Susan V Snijders; Silvie Hansenová Maňásková; Annelies Verbon; Willem J B van Wamel
Journal:  Infect Immun       Date:  2018-07-23       Impact factor: 3.441

9.  The Relationship between Glycan Binding and Direct Membrane Interactions in Vibrio cholerae Cytolysin, a Channel-forming Toxin.

Authors:  Swastik De; Adele Bubnys; Francis Alonzo; Jinsol Hyun; Jeffrey W Lary; James L Cole; Victor J Torres; Rich Olson
Journal:  J Biol Chem       Date:  2015-09-28       Impact factor: 5.157

10.  Exploiting dominant-negative toxins to combat Staphylococcus aureus pathogenesis.

Authors:  Tamara Reyes-Robles; Ashira Lubkin; Francis Alonzo; D Borden Lacy; Victor J Torres
Journal:  EMBO Rep       Date:  2016-02-08       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.